Is COMISA another opportunity for use of incretin drugs?

Saved in:
Bibliographic Details
Title: Is COMISA another opportunity for use of incretin drugs?
Authors: Pack AI; Division of Sleep Medicine/Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, United States.; Chronobiology and Sleep Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, United States., Grunstein R; Woolcock Institute of Medical Research, 2 Innovation Road, Macquarie Park, Sydney, NSW, Australia.; Macquarie University, Balaclava Road, Macquarie Park, Sydney, NSW 2113, Australia.; RPA-Charles Perkins Centre Clinic, Royal Prince Alfred Hospital, Sydney, NSW 2006, Australia., Mokhlesi B; Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Rush University Medical Center, 600 S. Paulina Street, Chicago, IL, 60612, United States., Ryan S; Pulmonary and Sleep Disorders Unit, St. Vincent's University Hospital, Elm Park, Dublin 4, D04 T6F4, Ireland.; School of Medicine, University College Dublin, Health Sciences Centre, Roebuck, Dublin, Ireland., Schwab R; Division of Sleep Medicine/Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, United States.; Chronobiology and Sleep Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, United States., Gozal D; Department of Pediatrics and Office of the Dean, Joan C. Edwards School of Medicine, Marshall University, 1600 Medical Center Drive, Huntington, WV, 25701, United States.
Source: Sleep [Sleep] 2025 Nov 10; Vol. 48 (11).
Publication Type: Editorial; Comment
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7809084 Publication Model: Print Cited Medium: Internet ISSN: 1550-9109 (Electronic) Linking ISSN: 01618105 NLM ISO Abbreviation: Sleep Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1550-9109
DOI:10.1093/sleep/zsaf254